Forced Vital Capacity as a Primary End Point in Idiopathic Pulmonary Fibrosis Treatment Trials: Making a Silk Purse From a Sow's Ear

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2012-202640
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Prognostic Value of Forced Expiratory Volume in 1 Second/Forced Vital Capacity in Idiopathic Pulmonary Fibrosis

Chronic Respiratory Disease
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis: Is All-Cause Mortality a Practical and Realistic End-Point for Clinical Trials?

Thorax
PulmonaryRespiratory Medicine
2013English

Body Mass Index—percent Forced Vital Capacity—respiratory Hospitalization: New Staging for Idiopathic Pulmonary Fibrosis Patients

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

"You Can't Make a Silk Purse Out of a Saw's Ear"

Chemical and Engineering News
Chemical Engineering
1966English

Clinical Trials in Idiopathic Pulmonary Fibrosis: A Framework for Moving Forward

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

A Critical Assessment of Treatment Options for Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Cyclosporin a in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Internal Medicine
Internal MedicineMedicine
2010English

FAM13A Polymorphism as a Prognostic Factor in Patients With Idiopathic Pulmonary Fibrosis

Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy